Urinary glycerophosphoinositol is a potentially non-invasive clinically applicable biomarker for CLN3 disease

Molecular Genetics and Metabolism 2026

View at publisher

Authors: Wendy Heywood, Ivan Doykov, Katy Vecchiato, Philippa B. Mills, Sara Mole, Paul Gissen

DOI: 10.1016/j.ymgme.2025.109463

Cited by: 0

Fields of Study & Subjects

Lysosomal Storage Disorders Research Metabolism and Genetic Disorders Glycogen Storage Diseases and Myoclonus